Santen Pharmaceutical Co., Ltd. (SNPHY)
OTCMKTS · Delayed Price · Currency is USD
11.03
-0.21 (-1.88%)
Jul 31, 2025, 3:43 PM EDT
Santen Pharmaceutical Market Cap
Santen Pharmaceutical has a market cap or net worth of $3.78 billion as of August 1, 2025. Its market cap has increased by 1.94% in one year.
Market Cap
3.78B
Enterprise Value
3.37B
Revenue
2.00B
Ranking
n/a
PE Ratio
15.60
Stock Price
$11.03
Market Cap Chart
Since January 14, 1992, Santen Pharmaceutical's market cap has increased from 1.19B to 3.78B, an increase of 217.43%. That is a compound annual growth rate of 3.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 3.78B | 7.40% |
| Dec 30, 2024 | 3.52B | -3.14% |
| Dec 29, 2023 | 3.63B | 15.53% |
| Dec 30, 2022 | 3.14B | -35.73% |
| Dec 30, 2021 | 4.89B | -24.57% |
| Dec 30, 2020 | 6.48B | -15.31% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo, Inc. | 1.80B |
| Veradigm | 823.67M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 519.96M |
| American Oncology Network | 408.39M |
| Glass House Brands | 396.28M |
| Northwest Biotherapeutics | 376.73M |
| Nika Pharmaceuticals | 366.89M |